Sort by
Refine Your Search
-
(EVs), for groundbreaking minimally invasive diagnostics. Uncover disease-specific molecules within EVs using cell biology and super-resolution microscopy. Contribute to developing a revolutionary
-
for Cancer and Aging is led by Dr. William Dale and is housed within the Supportive Care Research and Training Division. Our research program focuses on studies related to cancer and aging, exploring
-
other physician-scientists, translational science researchers, and key collaborators across the City of Hope system. Study priorities will be set by the Surgery Chair and Vice Chair. You will contribute
-
and providing recommendations for corrective action when necessary. Provide back-up support as needed for other CTMs and Portfolio Supervisors. Meet regularly with disease program leaders, investigators
-
program and its educational offerings. You will serve as a project manager, navigating the regulatory review process for each of their research studies, ushering manuscripts thru the submission and revision
-
Aging is led by Dr. William Dale and is housed within the Supportive Care Research and Training Division. Our research program focuses on studies related to cancer and aging, exploring the unique issues
-
a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer
-
& Therapeutics Research focuses on understanding how tumors evolve in response to treatment, using both bulk and single-cell omics approaches. We also develop AI/ML-enabled computational tools to predict
-
. The research program embraces team science drawing from i.e., implementation science, data science, geospatial, epidemiological, and machine learning approaches to better understand broad contexts including
-
, shaping the future of medicine through cutting-edge research. Dr. Xiuli Wang’s lab, part of the Therapeutics Research Laboratories program, is seeking a Research Associate II to support cutting-edge CAR T